PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -36.15% | -23.79% | 0.14% | 38.71% | 154.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.52% | 2.47% | 25.02% | 52.25% | 125.62% |
| Operating Income | 28.52% | -2.47% | -25.02% | -52.25% | -125.62% |
| Income Before Tax | 23.32% | 26.43% | 11.46% | -23.56% | -425.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.32% | 26.43% | 11.46% | -23.56% | -425.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.32% | 26.43% | 11.46% | -23.56% | -425.41% |
| EBIT | 28.52% | -2.47% | -25.02% | -52.25% | -125.62% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 88.83% | 80.10% | 66.86% | 37.91% | -684.60% |
| Normalized Basic EPS | 88.09% | 80.61% | 66.51% | 32.20% | -5,657.45% |
| EPS Diluted | 88.82% | 80.09% | 66.86% | 46.18% | -225.39% |
| Normalized Diluted EPS | 88.09% | 80.61% | 66.51% | 33.35% | -2,682.59% |
| Average Basic Shares Outstanding | 760.35% | 606.85% | 456.96% | 223.46% | 86.25% |
| Average Diluted Shares Outstanding | 760.35% | 606.85% | 456.96% | 217.56% | 82.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |